The molecular basis of hereditary complement factor I deficiency

被引:70
作者
Vyse, TJ
Morley, BJ
Bartok, I
Theodoridis, EL
Davies, KA
Webster, ADB
Walport, MJ
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,RHEUMATOL UNIT,LONDON W12 0NN,ENGLAND
[2] ROYAL FREE HOSP,LONDON NW3,ENGLAND
基金
英国惠康基金;
关键词
complement; factor I; mutation; genetics; immunodeficiency;
D O I
10.1172/JCI118515
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The molecular basis of hereditary complement factor I deficiency is described in two pedigrees. In one pedigree, there were two factor I-deficient siblings, one of whom was asymptomatic and the other suffered from recurrent pyogenic infections. Their factor I mRNA was analyzed by reverse transcription of fibroblast RNA followed by amplification using the polymerase chain reaction. Both siblings were homozygous for the same transversion (adenine to thymine) at nucleotide 1282 in the cDNA. This mutation causes histidine-400 to be replaced by leucine. The altered histidine is a semi-conserved residue within the serine proteinase family, although no function has been ascribed to it. The proband of the second pedigree studied was found to be a compound heterozygote. One allele had the same mutation as the first family, the second allele had a donor splice site mutation that resulted in the deletion of the mRNA encoded in the fifth exon (a low-density lipoprotein receptor domain) from its transcript.
引用
收藏
页码:925 / 933
页数:9
相关论文
共 44 条
[1]  
ABRAMSON N, 1971, J IMMUNOL, V107, P19
[2]  
AKLI S, 1990, J BIOL CHEM, V265, P7324
[3]   INACTIVATOR OF THIRD COMPONENT OF COMPLEMENT AS AN INHIBITOR IN PROPERDIN PATHWAY [J].
ALPER, CA ;
ROSEN, FS ;
LACHMANN, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (10) :2910-&
[4]   INCREASED SUSCEPTIBILITY TO INFECTION ASSOCIATED WITH ABNORMALITIES OF COMPLEMENT-MEDIATED FUNCTIONS AND OF THIRD COMPONENT OF COMPLEMENT (C3) [J].
ALPER, CA ;
ABRAMSON, N ;
JOHNSTON, RB ;
JANDL, JH ;
ROSEN, FS .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (07) :349-&
[5]   HUMAN-LEUKOCYTE AND PORCINE PANCREATIC ELASTASE - X-RAY CRYSTAL-STRUCTURES, MECHANISM, SUBSTRATE-SPECIFICITY, AND MECHANISM-BASED INHIBITORS [J].
BODE, W ;
MEYER, E ;
POWERS, JC .
BIOCHEMISTRY, 1989, 28 (05) :1951-1963
[6]   CHARACTERIZATION OF THE PRIMARY AMINO-ACID-SEQUENCE OF HUMAN-COMPLEMENT CONTROL PROTEIN FACTOR-I FROM AN ANALYSIS OF CDNA CLONES [J].
CATTERALL, CF ;
LYONS, A ;
SIM, RB ;
DAY, AJ ;
HARRIS, TJR .
BIOCHEMICAL JOURNAL, 1987, 242 (03) :849-856
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   DIRECT SEQUENCING OF ENZYMATICALLY AMPLIFIED HUMAN GENOMIC DNA [J].
ENGELKE, DR ;
HOENER, PA ;
COLLINS, FS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :544-548
[9]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[10]  
GOLDBERGER G, 1987, J BIOL CHEM, V262, P10065